Back to dashboard Episode 79

DIP Episode 79 - USMLE Step 1 Hematology Part 1

HematologyMedium4 - HighHas Q&A

Step 1Step 2Step 3MedicineUSMLEStep 1Step 2Step 3

Topic

Platelet disorders; Primary and secondary hemostasis; Coagulation cascade factors (Intrinsic vs. Extrinsic); Anticoagulant mechanisms and drugs.

Key Takeaway

Understanding the distinction between primary platelet plug formation (adhesion/aggregation) and stable fibrin clot formation (secondary coagulation) is critical, requiring knowledge of specific factor deficiencies (e.g., vWF, GP IIb/IIIa) and the roles of anticoagulant proteins like Protein C and Antithrombin III.

Runtime: 77.7 min

Published: 2019-02-14

Completed audio: Yes

Completed notes: Yes

Anki made: Yes

Section: HEME-ONC

Open Notion notes Episode source

Episode Notes

Source / episode info

Episode: 79
Title: Divine Intervention Episode 79 – USMLE Step 1 Hematology Part 1
Published: 2019-02-14
Source: Episode page

One-liner

This episode provides a deep dive into hematology, covering platelet disorders (vWD, Glanzmann's, ITP), detailing the two phases of hemostasis—primary (platelet plug) and secondary (fibrin clot)—and reviewing the complex coagulation cascade factors and associated anticoagulant pathways.

High-yield summary

Primary Hemostasis: Involves platelet adhesion to exposed subendothelial collagen via the {vWF} -> {GP I Ib/II Ia} interaction, forming a weak platelet plug.
Secondary Hemostasis: Stabilizes the plug by converting fibrinogen (Factor I) into stable fibrin ({Fibrin}_{{stable}}), primarily driven by Thrombin ({I Ia}) and cross-linked by Factor XIII.
Antiplatelet Drugs: Aspirin is an antiplatelet drug because it irreversibly inhibits {COX}, preventing the formation of {Thromboxane A}_2 ({TXA}_2), thereby inhibiting platelet aggregation (primary hemostasis).
Coagulation Monitoring: The Extrinsic pathway is monitored by PT/INR (Factors VII, X, V, II); the Intrinsic pathway is monitored by aPTT (Factors XII, XI, IX, VIII, X, V, II).
Protein C System: Factor {II} binding to Thrombomodulin activates Protein C. Activated Protein C pairs with Protein S to inactivate Factors {Va} and {VII Ia}, providing a negative feedback loop for coagulation.

Learning objectives

Differentiate the pathophysiology and diagnostic testing for common inherited bleeding disorders (e.g., vWD vs. Glanzmann's).
Describe the sequential steps of primary hemostasis (adhesion -> aggregation) and secondary hemostasis (fibrin stabilization).
Identify key antiplatelet drugs (Aspirin, P2 Y12 inhibitors) and their specific molecular targets (\text{COX}, ADP receptor).
Interpret coagulation screening tests (PT/INR vs. aPTT) to localize factor deficiencies within the intrinsic or extrinsic pathways.
Explain the role of natural anticoagulants (Protein C, Protein S, Antithrombin III) in regulating the coagulation cascade via negative feedback loops.

Board exam buzzwords

Condition	Key Finding	Association	Board Exam Tip
von Willebrand Disease ({vWD})	Mucocutaneous bleeding; Elevated Bleeding Time	{vWF} deficiency/dysfunction; Abnormal Ristocetin Cofactor Assay	Remember that {vWD} is the most common inherited bleeding disorder.
Glanzmann Thrombasthenia	Mucocutaneous bleeding; Elevated Bleeding Time	Defective platelet aggregation ({GP I Ib/II Ia})	The Ristocetin Cofactor Assay will be normal, differentiating it from {vWD}.
Immune Thrombocytopenic Purpura ({ITP})	Mucosal bleeding (gingival); Low Platelet Count	Autoantibodies against GP I Ib/II Ia; Viral trigger	Always think of {ITP} in a child following an upper respiratory infection.
Aspirin / Antiplatelets	Inhibition of COX-1	Prevents {TXA}_2 synthesis	Crucial Distinction: Aspirin is antiplatelet (primary hemostasis); Anticoagulants work on secondary hemostasis.

Rapid review table

Topic	Key Point	Context	Exam Relevance
Primary Hemostasis	Adhesion -> Aggregation ({vWF} -> {GP I Ib/II Ia})	Initial response to vascular injury; forms a weak plug.	Test differentiation between vWD (adhesion defect) and Glanzmann's (aggregation defect).
Secondary Hemostasis	Fibrinogen -> Stable Fibrin ({Fibrin}_{{stable}})	Stabilizes the platelet plug using Thrombin and Factor XIII cross-linking.	Understand that this phase is monitored by PT/aPTT, not bleeding time.
Antiplatelet Drugs	Target COX or ADP receptors	Prevents {TXA}_2 (COX inhibitors) or aggregation signals ({P}2{Y}_{12} inhibitors).	Aspirin and P2 Y12 inhibitors are the most common antiplatelets used in acute care.
Protein C System	Factor II + Thrombomodulin -> Activated PC	Negative feedback loop; inactivates Factors {Va} and {VII Ia}.	This mechanism is key to understanding how coagulation is naturally shut down.

Board-speak -> diagnosis

Board-speak / Vignette phrase	Diagnosis / Concept	Why it fits
A young child presents after a viral URI with easy bruising, mucosal bleeding (gingival), and normal PT/aPTT.	Immune Thrombocytopenic Purpura ({ITP})	{ITP} is an autoimmune condition where IgG antibodies target the platelet surface (specifically GP I Ib/II Ia), leading to splenic destruction.
A patient has mucocutaneous bleeding, elevated bleeding time, and a normal PT/aPTT. The Ristocetin Cofactor Assay is abnormal.	von Willebrand Disease ({vWD})	{vWF} deficiency impairs platelet adhesion to collagen. This defect is detectable by the Ristocetin Cofactor Assay (which measures vWF function).
A patient presents with mucocutaneous bleeding, elevated bleeding time, and a normal PT/aPTT. The Ristocetin Cofactor Assay is normal.	Glanzmann Thrombasthenia	Defect in platelet aggregation due to defective {GP I Ib/II Ia} receptor. Since adhesion (vWF) is intact, the Ristocetin assay remains normal.
A patient with severe bleeding has a history of chronic kidney disease and elevated INR despite receiving Vitamin K.	Antithrombin III Deficiency / Heparin-Induced Thrombocytopenia ({HIT})	Chronic kidney disease can lead to loss of {Antithrombin III}. {HIT} is an antibody-mediated consumption coagulopathy that consumes {ATIII}. Both result in hypercoagulability/bleeding risk.
A patient with a suspected bleeding disorder has normal PT and aPTT, but the physician suspects a defect in platelet adhesion.	von Willebrand Disease ({vWD})	The combination of normal PT/aPTT (ruling out major factor deficiencies) and an abnormal Ristocetin Cofactor Assay strongly points to {vWF} deficiency.
A patient is undergoing cardiac surgery and requires antiplatelet therapy, but the physician wants to avoid drugs that inhibit COX.	P2 Y12 Inhibitors (e.g., Ticagrelor) or direct thrombin inhibitors ({Dabigatran})	These agents target platelet aggregation pathways independent of {TXA}_2 synthesis, offering alternative antiplatelet coverage.

Differential diagnosis / distinguishing features

Coagulation Pathway Deficiencies

Key Features	Distinguishing Findings	Next Step
Extrinsic Pathway Deficiency	Prolonged PT/INR; Normal aPTT.	Test for Factor VII, X, V deficiency. Vitamin K replacement (if {VK} dependent).
Intrinsic Pathway Deficiency	Prolonged aPTT; Normal PT/INR.	Test for Factor XII, XI, IX, VIII deficiency. Replacement factor therapy.

Management pearls

Bleeding Disorder Workup: Always start by differentiating between platelet defects (primary hemostasis) and factor deficiencies (secondary hemostasis). If bleeding time is prolonged, suspect a primary defect (\text{vWD}, Glanzmann's, \text{ITP}).
Antiplatelet vs. Anticoagulant: Aspirin/Clopidogrel are antiplatelets; Heparin/Warfarin are anticoagulants. Never confuse the two mechanisms.
\text{vWF} Testing: The Ristocetin Cofactor Assay is a functional test that measures \text{vWF} binding ability and is crucial for differentiating \text{vWD} from Glanzmann's.
Severe Bleeding Management: For severe bleeding due to thrombocytopenia (\text{ITP}), administer IVIG or corticosteroids; do not rely solely on counting platelets.

Don't miss

🚨

The primary defect in \text{vWD} is the deficiency of \text{vWF}, which impairs platelet adhesion to collagen.

🚨

Aspirin inhibits \text{COX}-1 irreversibly, preventing \text{TXA}_2 synthesis and thus acting as an antiplatelet agent.

🚨

The coagulation cascade utilizes a negative feedback loop: Thrombin (\text{I Ia}) binding to Thrombomodulin activates Protein C, which then inactivates Factors \text{Va} and \text{VII Ia}.

🚨

\text{Antithrombin III} is consumed in conditions like nephrotic syndrome (protein loss) or heparin overdose, leading to a hypercoagulable state.

Integration & clinical reasoning

Nephrology/Hematology: Nephrotic Syndrome causes massive urinary protein loss, including \text{Antithrombin III}. This depletion of an anticoagulant leads to a significantly increased risk of thrombosis (\text{PE}, DVT).
Cardiology/Hematology: The understanding of the coagulation cascade is vital for managing patients with atrial fibrillation (risk of left atrial appendage thrombus) and those requiring cardiac stenting (antiplatelet therapy).
Pharmacology/Hematology: Understanding the \text{P}2\text{Y}_{12} receptor allows selection of appropriate antiplatelet agents (e.g., Clopidogrel for PCI, Ticagrelor for acute coronary syndrome).

OMM / COMLEX integration

🦴

For COMLEX: know these viscerosomatics / Chapman points, but don't let OMM distract from emergent diagnosis and management.

Standard emergency management for acute bleeding or suspected DIC takes priority over OMT. However, understanding the role of coagulation factors is relevant in managing trauma/massive transfusion protocols (MTP).
The concept of negative feedback loops (Protein C system) can be conceptually linked to inflammatory states where excessive clotting may occur, requiring systemic anti-inflammatory and anticoagulant management.

Concept connections / cross-references

For detailed information on coagulation factors and their roles in bleeding/thrombosis: [ Episode 37 ] (Coagulation Cascade)
For understanding the role of endothelial function and vascular tone: [ Episode 12 ] (Pulmonary Pharmacology)

High-yield association table

Condition	Association	Mechanism	Clinical Significance
{vWD}	Platelet Adhesion Defect	Deficiency/dysfunction of von Willebrand Factor ({vWF})	Causes mucocutaneous bleeding; requires specific testing (Ristocetin Cofactor Assay).
Glanzmann Thrombasthenia	Platelet Aggregation Defect	Defective {GP I Ib/II Ia} receptor on platelets.	Leads to severe mucosal bleeding, but the Ristocetin assay is normal.
Aspirin Use	Antiplatelet Action	Irreversible inhibition of platelet {COX}-1, preventing {TXA}_2 synthesis.	Used for primary prevention of cardiovascular events (e.g., ACS).
Protein C System	Negative Feedback Loop	Factor {II} on Thrombomodulin activates PC, which degrades Factors {Va} and {VII Ia}.	Failure in this system (or consumption) leads to hypercoagulability.

Key terms glossary

Term	Definition	Context	Example
Primary Hemostasis	The initial phase of clotting involving platelet adhesion and aggregation.	Occurs immediately upon vascular injury; forms a weak plug.	{vWF} binding to collagen via {GP I Ib/II Ia}.
Secondary Hemostasis	The stabilization of the platelet plug by forming a stable fibrin mesh.	Requires multiple clotting factors (e.g., Factors {II}, {XIII}).	Thrombin converting Fibrinogen ({I}) to Fibrin ({I}_{{stable}}).
Ristocetin Cofactor Assay	A functional test measuring the ability of plasma to promote platelet adhesion.	Used to diagnose {vWD} or other vWF defects.	Abnormal result suggests a defect in {vWF}.
{GP I Ib/II Ia} Receptor	Glycoprotein receptor on platelets that binds fibrinogen and {vWF}.	Essential for platelet aggregation; defective function causes Glanzmann's.	Inhibited by drugs like Abciximab or Eptifibatide during PCI.

Study optimization

Topic	Study Approach	Priority	Resources
Platelet Disorders	Create a differential table comparing {vWD}, Glanzmann's, and {ITP} based on lab findings (Ristocetin assay, platelet count).	High	Review board-style vignettes focusing on diagnostic workup.
Coagulation Cascade	Memorize the factors involved in the intrinsic vs. extrinsic pathways and the roles of natural anticoagulants ({PC}, {ATIII}).	Medium-High	Use flowcharts to trace factor activation (e.g., Factor {VII} -> PT).
Antiplatelet/Anticoagulant Drugs	Focus on mechanism of action and the specific pathway targeted (COX vs. Thrombin/Factor Xa).	High	Practice questions requiring drug selection based on clinical scenario (e.g., post-PCI care).

Question pattern recognition

The "Best Answer" Trap: When presented with a bleeding disorder, always confirm if the defect is in adhesion (\text{vWF}), aggregation (\text{GP I Ib/II Ia}), or factor deficiency (PT/aPTT).
Drug Mechanism Differentiation: Be able to distinguish between antiplatelet drugs (affecting primary hemostasis) and anticoagulants (affecting secondary hemostasis).
Systemic Disease Association: Recognize that chronic kidney disease, liver failure, and nephrotic syndrome can lead to hypercoagulable states due to loss of natural anticoagulants (\text{ATIII}, Protein C).

Test yourself

Common mistakes to avoid

🚫

Mistake 1: Confusing Antiplatelet vs. Anticoagulant. Aspirin and \text{P}2\text{Y}_{12} inhibitors are antiplatelets (affecting primary hemostasis); Heparin/Warfarin are anticoagulants (affecting secondary hemostasis).

🚫

Mistake 2: Misinterpreting the Ristocetin Assay. A normal result rules out \text{vWD}, but a normal result does not rule out Glanzmann's or ITP. The assay specifically tests vWF function.

🚫

Mistake 3: Assuming all bleeding disorders are factor deficiencies. Many common bleeds (e.g., \text{ITP}) are due to platelet count issues, not clotting factor defects.

Common traps

⚠️

The "Normal" Coagulation Test Trap: A patient with severe thrombocytopenia (\text{ITP}) may have a normal PT/aPTT because the defect is in the number of platelets, not the function of the factors.

⚠️

The \text{vWF} vs. Glanzmann's Trap: Both cause mucocutaneous bleeding and elevated bleeding time. The key differentiator is that \text{vWD} has an abnormal Ristocetin Cofactor Assay, while Glanzmann's does not.

⚠️

The Protein Loss Trap: When a patient loses plasma proteins (e.g., nephrotic syndrome), they lose natural anticoagulants like \text{ATIII}, leading to hypercoagulability and thrombosis risk, even if their clotting factors are normal.

Original transcript with highlights

Okay, welcome. My name is divine. I am a PGI one transitional year resident. It's ultimately going into radiology. This will be the 17 ninth episode of the Divine intervention podcast. And I'll be talking about a step one topic today. In fact, today I'm going to be talking about hematology. Again, this is going to be a free form podcast. What I'm going to try to do is I'm just going to try to introduce like classic clinical cases as we go along and I'll discuss them in the context of relevant step one material. And really my focus today is going to be primarily on platelets. But I'm going to discuss like, I mean, let's see how I don't really hoping to keep this to under an hour. So let's see how this goes. What my plan is to go for no more than an hour. But really I want to talk about platelets, talk about many of the platelet disorders. And then maybe get to like some hemolytic diseases, some like exotic diseases that you find in the realm of a hematology. Okay, so and I'm going to try to follow first state. Just sort of make sure that I sort of touch, cover my bases and basically cover the material in first state. So this is a methodology podcast will be in a series. So this will be part one. And again, there are no slides for this. I'm beginning to realize that people get a lot more from my lectures by taking notes. So I mean, every now and then I'll probably make slides. It is like absolutely necessary.

But for the foreseeable future, I'm just going to make podcasts without slides. You listen to them take notes. I think that's where a lot of learning and retention will come from. So let's begin. Right. So let's assume you get a question about a patient that has like just you know they always seem to have like skin PT. I. So you're like, maybe this person has some kind of bleeding disorder. Right. And then you measure the PT. It's completely normal. Right. But you measure the bleeding time and it's elevated. And then you're like, hmm, bleeding time is elevated. Let me do some more tested. And then you go ahead and you do something called the RISTO seating cofactor assay. Right. And you notice that that assay is negative. Right. So if you have these parameters at the back of your mind, what's your diagnosis? And think in terms of a genetic disorder. Right. So PT Ki think of pepper. Why not? PT PT is fine. Blint time is elevated. Well, the RISTO seating cofactor assays abnormal. Right. I mean, sorry is normal. Right. So it's like negative. So hopefully that so leads you away from a because obviously you know this is a plate plate disorder. Right. Because this patient is having plate plate style bleeding basically now talk about that later in the podcast. But this patient is having a plate plate style bleeding because they're having like mucus or surface bleeding. That's classic whenever patient has a plate plate disorder. But the RISTO seating cofactor assay is normal.

So that basically rules up a willy brand disease. And, and, uh, was the obvious of the problem, burn it so Lee syndrome. And also the PT T is fine. Right. So that definitely helps you allow a willy brand disease. So we're going to settle on glansman from the stevia as the cause of this patient's problem. And I'll talk about it as we go along. But with that case in point, let me go ahead and talk about sort of talk about like this coalition cascade. Right. So obviously we know the coalition cascade involves primary and secondary most thesis. Sort of like big picture. We know that primary hemostesis. It's like I sort of think of it this way. So if a patient is like super sick. Right. Let's say the coming they're super super sick coming to the ED. Basically the job of the ed physician is to stabilize them. Right. And then after the ed physician stabilizes them. His next point of college to move them to like I mean like the ICU right for for their management. Right. So I sort of think of primary hemostesis as the ed physicians job just sort of just know like just down and dirty medicine. Get the person's to be laced and then after that you ship the person off to the ICU. That's most secondary hemostesis. So really in primary hemostesis your job is you want to just quick and dirty play clip log. Okay. But the thing is that play clip log is not very strong. Right. So you probably want to try to you know, strengthen the little more.

So the way you do that is by secondary hemostesis. So let's sort of talk about primary hemostesis first. Right. So the first thing that happens is let's assume you're stabbed. Right. So you get a nick in your skin. Right. So you injure blood vessel. Okay. So how does your body deal with that problem? The first thing your body does is to viso construct right because think about it. Your body doesn't want to your body is your physiology is organized to hopefully make you not lose a lot of blood. So the first thing that happens is that you have like viso construction right that viso constructions sort of kind of like decreases blood flow. And it's like a local viso construction decreases blood flow like blood loss from the area of injury. Right. And the key thing you want to keep at the back of your mind for step one is that the key agent involved in that viso construction is endothelian. Right. Especially like endothelian one. Hopefully remember endothelian from my pulmonary pharmacology podcast right talked about pulmonary arterial hypertension where we said that oh endothelian is a powerful viso constructions. If I'm not mistaken is one of the most powerful viso constructors in the body. Right. So if you want to trip pulmonary arterial hypertension, you want to give an endothelian receptor antagonist. Right. Like 100% and 100% and we said that was an endothelian a receptor antagonist. Okay. So just one of those weird things weird times I guess I want to bring in here.

But basically you have that viso constructions to sort of like reduce blood loss. Right. And then you essentially have primary hemostasis happen and primary hemostasis. It's a relatively simple process with a lot of moving parts. Right. And I'll try to break it down for you. So the thing is in primary hemostasis right there is like the adhesion step right that's basically and that's basically where the the platelets sort of attached to collagen and then there's the activation step where like some magic happens that I'll talk about shortly. And then there is the aggregation step where you form the the weak platelet plug. Right. So the first thing that happens right when you have injury right you basically. I sort of think of it as like sort of scrubbing away the endothelial cells from the surface of blood vessels. So you scrub away those endothelial cells guess what lies below endothelial cells it's collagen. Right. That's why that collagen is called sub endothelial collagen. It's below endothelial cells. And that collagen once it's once it's basically exposed certain things flowing in the blood like like platelets will try to bind to it. But the thing is that binding sort of needs an intermediary right. So it sort of leads like a pastor to join that man a woman together. So how does that happen.

So the thing that happens is when you expose that sub endothelial collagen there is something known as a GP 1 B that you you have that GP 1 B that sort of you find on the surface of platelets. And then when we'll be in factor binds to that GP 1 B and then that when we'll be in factor GP 1 B complex binds to that sub endothelial collagen that's the adhesion process of primary hemostesis. And it is actually very high you to remember where when we'll be in factor comes from right these are just as we are here that your friends at the NBA me love to test on the US ML is right so it behaves you to remember that from will be in factor. You can actually find them in endothelial cells. Okay, don't forget that you can find them in a wide balladdy buddies. And then if you also look in platelets platelets have a certain granules like alpha granules the alpha granules of platelets actually contain a from will you burn factor. And while we're on this topic don't forget your lamella buddies in type 2 nyomo sites that help you store surfactant that's actually very high you to know for the US ML step one. Yeah, your friends at the NBA me love these like cytoplasmic inclusions and whatnot so just sort of keep those things at the back of your mind. Okay, so what are the key pathologies with this adhesion step right so this adhesion step you can have a deficiency of will you burn factor right where you just don't have a will you burn factor alternatively you can have.

And that's what's known as a vulnerable disease alternatively you can have a deficiency of GP won't be right basically if you have these two if you have a deficiency of either the adhesion step of primary he most this is not going to happen right and if you notice from the earlier we need I talked about I mentioned the Ristocitin co factor as a basically Ristocit is like an antibiotic that no one really knows how but basically if you put Ristocitin patients plasma you promote. That adhesion step of primary he most this is so if you have a deficiency of any of those things like when we burn factor.

Okay, if we burn disease or GP won't be a key burn at Sulea syndrome that Ristocitin co factor as they will be abnormal right so that Ristocitin co factor as is like a test it's like a nice test for one will you burn disease or for burn at Sulea syndrome right and one with them with because you may say I'll divine if they both have an abnormal Ristocitin co factor as a how do I tell those two apart and exams here's how you tell them apart right so they are both plated disorders right so obviously the person will have like mecoso bleeding and epistaxis and all that stuff fine okay and because it's also a pletaline disorder the bleeding time will be elevated because bleeding time is elevated in pretty much every pletaline disorder okay but one thing one thing that will help you on exams to differentiate between the willy brand disease and and again please excuse my arms and ass I'm giving this like this lecture literal from members so although I sort of have an outline of the way I'm doing this I'm giving this lecture literal from members so although I sort of have an outline of the way I'm doing this I'm giving this lecture literal from members so although I sort of have an outline of the way I'm doing this I'm giving this lecture literal from members so I'm giving this lecture literal from members so although I sort of have an outline of the way I'm giving this lecture literal from members so I'm giving this lecture literal from members so although I sort of have an outline of the way I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm gi

ving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal fr

om members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving thi

s lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture literal from members so I'm giving this lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture le

cture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lectur

e lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture le

e lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture lecture So, really if you keep that at the back of your mind that oh low cyclic Mp is good for primary hemostasis that should tell you that oh high cyclic Mp is good if you want to be an anti-plit lead drug right so that's how drugs like a selloxtozole and diperedum or work they are phosphodistories in hemeders mine hebe an phosphodistories you decrease the breakdown of cyclic Mp so cyclic Mp builds up a cyclic Mp builds up you basically inhibits that you basically like stopping that activation step of primary hemostasis because you are essentially reversing the effects of the signaling cascade through the edp receptor and please don't forget that the edp receptor is also known as the p2y12 receptor and it's blocked by drugs like a clopidogrel and prestogrel and and tyclopidine and tyclagrelo right so those are your p2y12 receptor blockers although I talk about all these drugs in the in my hema from a colgipo

tcacel we encourage you to sort of go back and look at those.

And then one high ophthalgy you want to sort of keep at the back of your mind is that gp 2b3 right I just talked about that as being involved in the in the aggregation step of primary hemostasis if you had a deficiency of that well you have issues with quickly. You have issues with quickly aggregation right and that disease known as glansman thrombostemia right but remember that was basically the diagnosis for the case I posed earlier right and the reason I posed that question is that basically for patient has glansman thrombostemia they do not form.

They would do have a normal restocetene cofactor as a because it's a quickly aggregation problem it's not a quickly adhesion problem and they'll also have an invaded bleeding time because it's a very clear issue but the pt and pt will be completely normal okay because again gp 2b3 does not have any like extra life function like when will your factor does and one thing I'll just sort of mention so that sort of serves as a tip of an issue is that glansman thrombostemia and and and Bernatioly disease they are usually on exams associated with like large mega-cario sites if you do like a bone marrow smear or something like that so just one of those weird things you want to keep keep at the back of your mind and then remember that they are drugs that have the ability to block the gp 2b3 receptor right so they are drugs like ab 6imab that's like a monoclonal antibody and there's a drug known as a tyrophiban right and then there's another drug I believe it's a small molecule is known as a eptifibatite they all block those gp 2b3 receptors right and one other thing you may also want to think about with the gp 2b3 receptor is this disease known as immune thrombocytopenic itepi immune thrombocytopenic pepper classically right that will present on exams as like a kid that recently had like an upper respiratory viral infection right and then they tell you that that kid as they were brushing their teeth they notice like a lot of like gingival bleeding and then they are mumbrin and then you check the epitlic comes like two you're like that's weird right if you ever see that think about itp right itp right so it's just like an isolethe thrombocytopenia and really for the most part you don't treat what if those people have like severe bleeding or the epitlic count is like super low you can give them like steroids or you can give them an IVIG okay so in itp basically the thing that happens

is you make antibodies against gp 2b3 you make itgg antibodies against the gp 2b3 right and then those IgG antibodies obviously right they can remember that IgG can activate the classic complement cascade so that constant region of the IgG can be bound by complement and you basically destroy your platelets that way okay so that's why you have the thrombocytopenia part in itp okay so that's the classic way it presents on exams just how you think you want to know and then under drug right I guess I could talk about or a molecule that's released in that activation step right so that's like the second step of primary hemostesis is something known as a thrombocyn 82 okay thrombocyn 2 the thing is thrombocyn 2 right so think of it thrombocyn right so think of it as something that is thrombogenic thrombocyn basically promotes pleatin aggregation okay and the thing is thrombocyn 2 is actually made through that arachidonic acid cascade right so from like cycloxygenase so that's why a drug like aspirin is a good anti-plitle drug please don't make this mistake aspirin is an anti-plitle drug is not an anti-quagulant an anti-quagulant by definition is a drug that works on secondary hemostesis an anti-plitle drug by definition is a drug that works on primary hemostesis so aspirin irreversibly inhibits cycloxygenase so when inhibits cycloxygenase you do not make thrombocyn 2 so you basically inhibit the formation of thrombocyn 2 so you don't have a pleatin aggregation that's why aspirin is an anti-plitle drug so and then I guess you can think of like the anti thrombocyn 2 things like a prostacicline like PGI2 think of PGI2 as like pleatin gathering inhibitor okay those things inhibit pleatin aggregation okay and they also made through that arachidonic acid cascade right so things like prostacicline so like PGI2 mitric oxide right those things also inhibit a pleatin aggregation and they also

very good visodylators right so if for example you wanted to keep a pleatin doctor satirio if you wanted to keep a doctor satiriosus open see for example if a kid has like a cyanotic congenital heart defect you can give a prostacicline analog right so like a prostadil for example so again just one of those weird things you want to keep at the back of your mind the back of your mind for example so I think I have said all the higher things I want to say about primary hemostesis so I guess I can you know why don't I jump on to my next topic on to discuss which will be secondary hemostesis but before we do that let's talk about a clinical case right so let's assume you get a question okay about a person from Greece right and whenever I think of Greece I think of the Ianisantheto kompo the Milwaukee box guy but they are the different stories so back to the real world so let's see you have a person from Greece okay and for some reason they keep having you know just recurrent like they've had like let's say it's like a 20 year old that has had like 5 p.e.s like 5.4 million and they've had like multiple dvts and whatnot right and they give it as like a non-descript question on the usml and the s for the diagnosis well hopefully you're thinking about factor 5 lighting in fact factor 5 lighting if I'm not mistaken is the most common actually very high you to know that this is more step 2 question but it's the most common hyperquagulable disorder okay so factor 5 lighting basically arises where you have factor 5 that just refuses to be broken down by protein C and protein s so I'll talk about the mechanism behind that as we sort of proceed through secondary hemostesis so we say that primary hemostesis right to basically end at that plate led aggregation step where gp 2b3a right is bound by bound by fiber in origin of factor 1 right and that basically forms the weak plate led bloc

k so the thing is fiber in origin right origin right so that's like a Zymogen so you want to get it to something that's a little more stable so that you can essentially stabilize that plate led block okay so that would be that would be the whole point of secondary hemostesis so now you're sending those super sick stabilize patients to the ICU right you're basically trying to change that fiber in origin to fiber in okay fiber in origin is actually factor 1 you want to change it to fiber in okay that's like factor 1a if you may and then by doing that you basically stabilize the plecary block right so obviously that's where secondary hemostesis sort of comes into play and the thing about secondary hemostesis is there's two parts okay so there is the extrinsic part there's like the extrinsic cascade and there's the intrinsic cascade and the thing is there's a crap ton of factors that sort of work along these cascades the thing I will just tell you right of the bat is you don't necessarily need to remember all the steps where you absolutely positive I will say to be honest it probably just makes sense to remember all the steps because there's just so many pathologies along the way but at the same time I probably let's say you're like divine I there's no way I can remember all the stuff what you can do is you can just you know try to remember at least the clotting factors in the intrinsic versus the extrinsic cascade because it will help you answer certain questions especially with the hemophilia and PT's and I in ours and all that stuff and I'll talk about that right now actually so let's sort of walk through the different cascades so let's do the simple one first right so the extrinsic cascade the extrinsic cascade it's actually not that bad it basically involves factor 7 right factor 7 sort of is the big thing in that cascade and also I guess factor 3 another name for fa

ctor 3 is actually tissue factor right so basically tissue factor right or factor 3 converts like factor 7 to like its active form factor 7 okay and then that factor 7 has the ability to convert factor 10 to factor 10 a okay and then that factor 10 a can help you convert like pro thrombin which is factor 2 to thrombin which is activated factor 2 right and then that thrombin can then go ahead and convert that fiber inogen or factor 1 that bound to GP to be 3 to fiber okay although one thing I'll go ahead and say is that that fiber you actually do not just leave it at that the thing is that fiber is you actually form like even more stable cross links in that fiber with with something known as factor 13 okay factor 13 factor 13 basically establishes some really awesome cross links in that fiber so you form an even more stable pleated block the thing is if you wanted to go from that factor 13 to like the activated factor 13 you actually also do that with factor 2 right so thrombin has multiple jobs in fact I will tell you that for purposes of you exam think of thrombin of factor 2 a right as having three jobs right so I already mentioned to the first thing is it converts fiber inogen to fiber right and then the second thing is that it helps you convert factor 13 to factor 13 a and that factor 13 e like I said helps you establish you know pretty nice cross links within between fiber so that you can have a most stable pleated block the third rule is that in fact I'll talk about I'll let me hold my horses for now I'll sort of talk about that in a bit but that's really the extrinsic cascade really the way you monitor the extrinsic cascade is with something called PT INR okay that's the way you monitor that extrinsic cascade versus the intrinsic cascade that is monitored with like with a PT right and I'll in my him from a college podcast I talked about how PT PT INR and all th

at stuff sort of related to the heprin and the war friends so again I'll encourage you to go back and listen to those podcasts they are like one of my earlier podcasts when I started this website so so with the intrinsic cascade right so what so I guess let me sort of summarize for the extrinsic cascade basically think of factor 7 factor 3 right and then everything after factor 10 and everything after 10 really is factor 10 itself right and then factor factor 2 although the thing is for factor 10 to actually convert factor 2 to its active form it actually uses factor 5 as a co factor okay so basically again extrinsic cascade think of 7 3 3 is a tissue factor think of 10 think of 5 think of 2 and think of 1 okay so just sort of remember it in ascending order so like 1 2 3 5 7 and yeah that's it so 1 2 3 5 7 okay 1 2 3 5 7 1 2 3 5 7 and also 10 I guess so 1 2 3 5 7 so 1 2 3 5 7 and 10 and you're good to go in the extrinsic cascade the intrinsic cascade again also gets to factor 10 but the thing is prior to getting there you have like factor 12 going to factor 12 a and then 12 a converts 11 to 11 a and then 11 a converts factor 9 to 9 a okay and then factor 9 a uses factor 8 a to convert factors factor 10 to 10 a okay and then factor 10 again uses factor 5's help to convert factor 2 that's pro thrombing to 2 a that's thrombing and then you go from a fiber in origin to fiber okay and then remember that again factor 13 the activity form of factor 13 helps you with you know forming awesome cross links between those between a fiber so really for the intrinsic cascade the big thing I want to remember is it involves factors 12 11 9 and 8 and then everything after factor 10 right so 12 11 9 and 8 so 8 9 11 12 8 9 11 12 okay and then everything from factor 10 okay and really if you remember that you are good to go for the most part and the reason you need to remember this is aga

in you'll see as I begin to talk about the different hemophilias everything will sort of begin to fall into line nicely so I said that but actually so I've talked about the intrinsic cascade and extrinsic cascade but the thing is there actually some other high your things you sort of want to know here so the thing is if you notice if like if you look at that factor 10 step one step that comes before it in the intrinsic cascade is where factor 9a uses the help of factor 8a to help you convert factor 10 to factor 10a and then right after that factor 10 is step in converting for thrombin of factor 2 to thrombin of factor 2a you have factor 5 helping in that process so I thought sort of think of factor 8 and factor 5 as helpers of secondary most cases well here's the thing it so happens that those helpers are truly inhibited by a protein known as protein C okay and the thing is protein C does not act a known it has like a partner in crime okay that partner in crime is think of it as like a co factor protein S and the thing is protein C actually cannot do its dirty deeds without being activated right so the thing is protein C sort of like a dead doesn't work but if you change it to activate a protein C it becomes like like the incredible hope okay so to get it from protein C to activated protein C that really need the help of factor 2 factor to actually binds to something called a thrombomodulin and then that factor 2 thrombomodulin complex essentially converts protein C to activated protein C and then that active it that protein C sort of pairs up with this partner in crime protein S and then they inhibit those helpers of secondary most cases factors 8 and factor 5 right so sort of think of this as like a nice way that factor 2 can be done so that factor 2 can sort of shut down like it's kind of like a negative feedback mechanism for factor 2 with regards to secondary and

most cases right so I say that factor 2 has 3 jobs so I just mentioned the third job so let's sort of summarize so factor 2 the first job is to convert factor 1 of fiber nudging to factor 1 a of fiber second thing is factor 2 actually converts factor 13 to factor 13 a right so that's where remember factor 13 a helps you like from awesome cross links between a fiber and then the third job of factor 2 is that it binds to thrombomodulin and then that complex right the thrombomodulin complex converts protein C to activated protein C and then that activity protein C joins already it's partner in crime protein S to inhibit factors 8 and 5 okay just one of those three things you want to keep at the back of your mind and then there is something known as antithrom in 3 and then 3 is a nice molecule that basically helps you inhibit factors 10 and factor 2 okay and then it's factor 10 and 2 factor 10 and 2 factor 10 and 2 antithrom in 3 and then it's those things and again I apologize like I have a super super sorry that I'm in on detail all this detail but I promise you all this detail is very high for step 1 so don't say oh this is as we know you know I promise you it's not low yield is one of those rare things I'm a C on step you you like this on step 1 and then believe it or not some of these things pop up on exams like step 2 CK and step 3 many people think that after step 1 we can weave a final goodbye to basic sciences unfortunately that's not the case basically I think of step 1 as the USML exam that has the greatest proportion of basic science questions and then step 3 has the least proportion of basic science questions so on all the USM Ls you always see basic science questions is just a matter of just a matter of how many okay so just one of those things you want to keep at the back of your mind so let's talk about some high yield stuff with these pathways right so fi

rst thing I talked about is antithrom being 3 right antithrom being 3 in the him from a college podcast you remember me talking about heppere that basically super charges the effect the ability of antithrom being 3 so that you can inhibit factors 10 and factor 2 so more that's why heppere right that's as an awesome anticoagulant but if your friends at the mbmi want to integrate antithrom being 3 with nephrodite syndrome remember in nephrodite syndrome right where you basically p out more than 3.5 grams of protein in a 24 hour period those people unfortunately right let go of antithrom being 3 in the year right so think about it if you let go of antithrom being 3 in the year basically you're essentially you're essentially hyper coagulable that's why kidney disease kidney disease the phrodite syndrome is bad right because you're basically hyper coagulable because you're losing anticoagulant in this case antithrom being 3 in your year if you lose that antithrom being 3 in your year in factors 10 and factors 2 work on a post so you're hyper coagulable right another high yield with a consultant degree this is people that actually have a deficiency of antithrom being 3 for patient has a deficiency of antithrom being 3 right so obviously if you give those people heppere they will not respond to it much right you would basically they can give it on the nice way they can put an exam is a patient gets heppere like at the right time right those right everything and then they tell you that the patient still got like a PE or a DVT while being on heppere that's kind of odd right so that should sort of lead you down that pathway another way they can sort of mess with your head you know more comprehensively is to basically tell you like give you like an experimental question right so like these questions with the give experiments on the USML Es and then they talk about like controls s

o they can talk about like around the mice trial or whatever talk about like 2 groups of patients they talk about controls and they say oh these people got an agent and the agent basically let's say they are a baseline I can remember the normal values of the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient a

nd the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patie

nt and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the and the patient and the patient and the patient and the patient and the patient a

nd the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and t

he patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient a

nt and the patient and the patient and the patient and the patient and the patient and the patient and and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patie

nt and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient a

nt and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient a

nd the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and t

he patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patie

nt and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient and the patient a

I don't know if that's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It is me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me.

It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It is me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me.

It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It 's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me.

It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It's me. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is.

It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is. It is.

Practice questions — USMLE style

Question 1 — Hematology/Primary Hemostasis

A 30-year-old man presents with mucosal bleeding and epistaxis. Laboratory testing reveals a normal Prothrombin Time (PT) but an elevated bleeding time. Further specialized coagulation testing shows that the Ristocetin Cofactor Assay is significantly decreased. Based on these findings, which of the following genetic platelet disorders is most likely responsible for his bleeding symptoms?

A) Glanzmann thrombasthenia
B) Bernard-Soulier syndrome
C) von Willebrand disease
D) Immune thrombocytopenic purpura (ITP)

Answer: C. The combination of mucosal bleeding and an abnormal Ristocetin Cofactor Assay strongly suggests a deficiency in von Willebrand factor (vWF). vWF is crucial for the adhesion phase of primary hemostasis, binding platelets to exposed subendothelial collagen via GP Ib. Glanzmann thrombasthenia involves defective platelet aggregation (GP I Ib/II Ia), and Bernard-Soulier syndrome involves defective platelet adhesion due to a defect in the GP Ib receptor itself.

Question 2 — Pharmacology/Hemostasis

A patient is scheduled for elective surgery and has a history of poor wound healing and recurrent deep vein thrombosis (DVT). The physician orders an antiplatelet agent that works by irreversibly inhibiting cyclooxygenase (COX), thereby reducing platelet aggregation. Which class of drugs achieves this effect, and what is the primary mechanism?

A) P2 Y12 receptor antagonists; blocking ADP signaling to prevent platelet activation.
B) Thrombin inhibitors; preventing conversion of fibrinogen to fibrin.
C) Cyclooxygenase inhibitors; decreasing the formation of thromboxane A2 (TXA2).
D) Protein C activators; enhancing the inactivation of Factor V and Factor VIII.

Answer: C. Aspirin is a classic example of an antiplatelet drug that irreversibly inhibits cyclooxygenase (COX). This inhibition prevents the synthesis of potent platelet aggregatory agents, such as thromboxane A2 ($\text{TXA}_2$), thus impairing primary hemostasis and reducing platelet aggregation. P2 Y12 antagonists (like clopidogrel) block ADP receptors; Thrombin inhibitors target secondary coagulation factors.

Question 3 — Nephrology/Coagulation

A patient with advanced chronic kidney disease develops a history of recurrent pulmonary embolism despite receiving standard anticoagulation therapy. Laboratory evaluation reveals significantly low levels of Antithrombin III (ATIII). This clinical picture is most likely due to which underlying condition?

A) Liver failure, leading to impaired synthesis of clotting factors.
B) Vitamin K deficiency, impairing the synthesis of Factors II, VII, IX, and X.
C) Nephrotic syndrome, resulting in urinary loss of natural anticoagulants.
D) Severe malnutrition, causing generalized platelet dysfunction.

Answer: C. In nephrotic syndrome, massive proteinuria leads to the urinary loss of various plasma proteins, including Antithrombin III (ATIII). Since ATIII is a critical inhibitor of several key coagulation factors (especially Factor X and Factor II), its deficiency results in an acquired hypercoagulable state, predisposing the patient to venous thromboembolism.

Question 4 — Hematology/Primary Hemostasis

A child presents with petechiae and gingival bleeding following a viral upper respiratory infection. Laboratory testing reveals isolated thrombocytopenia without evidence of systemic illness or peripheral destruction. The most likely diagnosis is Immune Thrombocytopenic Purpura (ITP). Pathophysiologically, the primary mechanism leading to platelet destruction in ITP involves:

A) Direct consumption of platelets due to excessive activation of the intrinsic coagulation cascade.
B) Antibody-mediated clearance of platelets via complement activation on the surface of the platelets.
C) Failure of Factor XIII to stabilize the fibrin clot structure.
D) Deficiency of von Willebrand factor, leading to impaired platelet adhesion.

Answer: B. ITP is an autoimmune disorder where antibodies (often IgG) are produced against platelet components, particularly GP I Ib/II Ia. These antibodies activate the classical complement cascade, leading to the opsonization and subsequent destruction of platelets by macrophages in the spleen and liver.

Quick fire review

What is the primary function of vascular constriction during hemostasis?

To locally decrease blood flow at the site of injury, minimizing immediate blood loss.

Name the key agent involved in initiating vascular constriction.

Endothelin (Endothelin-1).

Which factor mediates the adhesion step of primary hemostasis by binding to subendothelial collagen?

von Willebrand Factor (vWF) binds to GP Ib on platelets, which then adheres to exposed collagen.

What is the key difference between an antiplatelet drug and an anticoagulant?

Antiplatelets work on primary hemostasis (e.g., inhibiting platelet aggregation); anticoagulants work on secondary hemostasis (e.g., inhibiting clotting factors).

Name two of Thrombin's three major jobs in coagulation.

1) Converting fibrinogen to fibrin; 2) Activating Factor XIII to stabilize the clot; 3) Binding to Thrombomodulin, which converts Protein C to activated Protein C (APC).

What is the primary diagnostic test used to differentiate between Von Willebrand disease and Glanzmann thrombasthenia?

The Ristocetin Cofactor Assay. VWD causes an abnormal result because it impairs adhesion; Glanzmann's does not affect adhesion, so the assay remains normal.

What is the role of Protein C/Protein S in coagulation?

They form a complex that activates Protein C (to APC), which then acts as a negative feedback loop by degrading Factors Va and VII Ia.

Which factor deficiency leads to impaired platelet adhesion, resulting in a positive Ristocetin Cofactor Assay?

Von Willebrand Factor (vWF) deficiency (Von Willebrand Disease).

What is the specific mechanism of action for aspirin as an antiplatelet drug?

Aspirin irreversibly inhibits Cyclooxygenase (COX), preventing the formation of Thromboxane A2 ($\text{TXA}_2$) and thus inhibiting platelet aggregation.

Which factors are primarily involved in the intrinsic coagulation cascade?

Factors XII, XI, IX, and VIII.

What is the clinical presentation associated with ITP that should prompt suspicion for this diagnosis?

Mucosal bleeding (e.g., gingival bleeding) following a recent upper respiratory viral infection in a child.

Which molecule helps stabilize the platelet plug formed during primary hemostasis by cross-linking fibrin?

Factor XIII (Fibrin stabilizing factor).

Quick recall / Anki-style questions